Alcon Inc. (ALC)
Automate Your Wheel Strategy on ALC
With Tiblio's Option Bot, you can configure your own wheel strategy including ALC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ALC
- Rev/Share 20.077
- Book/Share 44.4738
- PB 1.9509
- Debt/Equity 0.2361
- CurrentRatio 2.7012
- ROIC 0.0439
- MktCap 42881820000.0
- FreeCF/Share 3.4748
- PFCF 24.926
- PE 38.326
- Debt/Assets 0.1675
- DivYield 0.0038
- ROE 0.0695
- Rating
- Score
- Recommendation
- P/E Score
- DCF Score
- P/B Score
- D/E Score
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | ALC | Deutsche Bank | Buy | Hold | -- | -- | May 20, 2025 |
| Reiterated | ALC | BTIG Research | -- | Buy | $102 | $99 | May 14, 2025 |
| Reiterated | ALC | Needham | -- | Buy | $107 | $110 | March 28, 2025 |
| Upgrade | ALC | BofA Securities | Neutral | Buy | -- | -- | March 25, 2025 |
| Reiterated | ALC | Needham | -- | Buy | $108 | $106 | Jan. 24, 2025 |
| Upgrade | ALC | Redburn Atlantic | Neutral | Buy | -- | -- | Jan. 10, 2025 |
| Reiterated | ALC | Needham | -- | Buy | $103 | $108 | Dec. 17, 2024 |
| Upgrade | ALC | Redburn Atlantic | Sell | Neutral | -- | -- | Oct. 10, 2024 |
| Upgrade | ALC | RBC Capital Mkts | Sector Perform | Outperform | -- | -- | Sept. 10, 2024 |
News
Turkey Contact Lens Market - Competition, Forecast & Opportunities to 2030, Featuring Tech Contactlens, Diafarma, Alcon Laboratories, Diplomat Optics, Hoya Turkiye, ZEISS Turkiye, Keralens & more
Published: May 26, 2025 by: GlobeNewsWire
Sentiment: Neutral
The Turkish Contact Lens Market, valued at USD 55.15 Million in 2024, is set to reach USD 91.08 Million by 2030, at a CAGR of 8.68%. Growth is driven by rising vision correction awareness and demand for cosmetic lenses. The Turkish Contact Lens Market, valued at USD 55.15 Million in 2024, is set to reach USD 91.08 Million by 2030, at a CAGR of 8.68%. Growth is driven by rising vision correction awareness and demand for cosmetic lenses.
Read More
Alcon Inc. (ALC) Q1 2025 Earnings Call Transcript
Published: May 14, 2025 by: Seeking Alpha
Sentiment: Neutral
Alcon Inc. (NYSE:ALC ) Q1 2025 Earnings Conference Call May 14, 2025 8:00 AM ET Company Participants Dan Cravens - Vice President, Investor Relations David Endicott - Chief Executive Officer Tim Stonesifer - Chief Financial Officer Conference Call Participants Veronika Dubajova - Citi Jack Reynolds-Clark - RBC Capital Markets Graham Doyle - UBS Ryan Zimmerman - BTIG David Saxon - Needham & Company Larry Biegelsen - Wells Fargo Patrick Wood - Morgan Stanley Anthony Petrone - Mizuho Group Tom Stephan - Stifel Brett Fishbin - KeyBanc Capital Markets Young Li - Jefferies Jeff Johnson - Baird David Adlington - JPMorgan …
Read More
Alcon Q1 Earnings Miss Estimates, Stock Down, 2025 EPS View Lowered
Published: May 14, 2025 by: Zacks Investment Research
Sentiment: Negative
ALC ends the first quarter of 2025 on a disappointing note.
Read More
Ahead of Alcon (ALC) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Neutral
Evaluate the expected performance of Alcon (ALC) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Read More
Alcon Announces Results of 2025 Annual General Meeting
Published: May 06, 2025 by: Business Wire
Sentiment: Neutral
GENEVA--(BUSINESS WIRE)--Alcon Announces Results of 2025 Annual General Meeting.
Read More
Alcon Announces Results of 2025 Annual General Meeting
Published: May 06, 2025 by: Business Wire
Sentiment: Neutral
GENEVA--(BUSINESS WIRE)--Alcon Announces Results of 2025 Annual General Meeting.
Read More
Alcon Publishes Agenda for 2025 Annual General Meeting
Published: April 04, 2025 by: Business Wire
Sentiment: Neutral
GENEVA--(BUSINESS WIRE)--Alcon Publishes Agenda for 2025 Annual General Meeting.
Read More
Alcon Publishes Agenda for 2025 Annual General Meeting
Published: April 04, 2025 by: Business Wire
Sentiment: Neutral
GENEVA--(BUSINESS WIRE)--Alcon Publishes Agenda for 2025 Annual General Meeting.
Read More
ALC Stock May Rise With the Introduction of PanOptix Pro in US
Published: April 03, 2025 by: Zacks Investment Research
Sentiment: Neutral
Alcon introduces Clareon PanOptix Pro IOL to select practices across the United States, with commercial availability expected in May.
Read More
LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR
Published: March 26, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of LENSAR, Inc. (NasdaqCM: LNSR) to Alcon Inc. (NYSE: ALC). Under the terms of the proposed transaction, shareholders of LENSAR will receive $14.00 in cash, with an additional non-tradeable contingent value right offering up to $2.75 per share in cash conditioned on achievement of a milestone, for each.
Read More
Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities
Published: March 25, 2025 by: Business Wire
Sentiment: Neutral
GENEVA--(BUSINESS WIRE)--Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities.
Read More
Alcon Agrees to Acquire LENSAR, Inc.
Published: March 24, 2025 by: Business Wire
Sentiment: Neutral
GENEVA, Switzerland & ORLANDO, Fla.--(BUSINESS WIRE)--Alcon Agrees to Acquire LENSAR, Inc.
Read More
Retinal Surgery Devices Market Outlook Report 2025-2033: Revenues Set to Double, Reaching $4.83 Billion by 2033, Led by Topcon Corp., Alcon, and Carl Zeiss
Published: March 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
Dublin, March 24, 2025 (GLOBE NEWSWIRE) -- The "Retinal Surgery Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ResearchAndMarkets.com's offering. The Retinal Surgery Devices Market is expected to reach US$ 4.84 billion in 2033 from US$ 2.48 billion in 2024, with a CAGR of 7.71% from 2025 to 2033. Some of the main reasons propelling the market include the rising prevalence of a number of eye ailments, increased awareness of eye issues and available treatments, and the expanding use of minimally invasive (MI) surgical technology. Rising prevalence of retinal diseases The …
Read More
Alcon to Host 2025 Capital Markets Day
Published: March 13, 2025 by: Business Wire
Sentiment: Neutral
GENEVA--(BUSINESS WIRE)--Alcon to Host 2025 Capital Markets Day.
Read More
Alcon to Host 2025 Capital Markets Day
Published: March 13, 2025 by: Business Wire
Sentiment: Neutral
GENEVA--(BUSINESS WIRE)--Alcon to Host 2025 Capital Markets Day.
Read More
Watch CNBC's full interview with Alcon CEO David Endicott
Published: February 26, 2025 by: CNBC International TV
Sentiment: Neutral
Alcon CEO David Endicott discusses the pharmaceutical firm's full-year results.
Read More
Alcon Inc. (ALC) Q4 2024 Earnings Call Transcript
Published: February 26, 2025 by: Seeking Alpha
Sentiment: Neutral
Alcon Inc. (NYSE:ALC ) Q4 2024 Earnings Conference Call February 26, 2025 8:00 AM ET Company Participants Dan Cravens - Vice President, Investor Relations David Endicott - Chief Executive Officer Tim Stonesifer - Chief Financial Officer Conference Call Participants David Saxon - Needham & Company Jeff Johnson - Baird Ryan Zimmerman - BTIG Larry Biegelsen - Wells Fargo Julien Ouaddour - Bank of America Patrick Wood - Morgan Stanley David Adlington - JPMorgan Brett Fishbin - Keybanc Capital Markets Harry Shrives - Citi Tom Stephan - Stifel Issie Kirby - Redburn Atlantic Kavya Deshpande - UBS Jack Reynolds-Clark - RBC …
Read More
Alcon Q4 Earnings Beat, Margins Rise, Stock Remains Stable in Afterhours
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Positive
ALC's performance is driven by robust demand for its innovative products, balanced geographic footprint and strong execution by the team.
Read More
Alcon eyes revenue growth in 2025 after in-line results
Published: February 26, 2025 by: Reuters
Sentiment: Positive
Alcon forecast sales of between $10.2 and $10.4 billion for 2025, after the eye care group reported higher fourth-quarter revenue underpinned by its surgical division on Tuesday.
Read More
Alcon (ALC) Reports Q4 Earnings: What Key Metrics Have to Say
Published: February 25, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Alcon (ALC) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
About Alcon Inc. (ALC)
- IPO Date 2019-04-09
- Website https://www.alcon.com
- Industry Medical - Instruments & Supplies
- CEO Mr. David J. Endicott
- Employees 25599